191307 Practical considerations in evaluating and implementing AI solutions for today’s clinical laboratorian

Sun., July 26 | 9:00 AM – 4:00 PM | Room

191206 Quantifying diagnostic impact: Causal inference and real-world data in practice

Sun., July 26 | 1:00 PM – 4:00 PM | Room

32445 Navigating reimbursement and coding: The basics, AI, and emerging healthcare technologies

Mon., July 27 | 12:30 PM – 2:00 PM | Rm 207CD

32446 Petri dishes and pixels: Applying digital imaging solutions to contemporary clinical microbiology practice

Mon., July 27 | 12:30 PM – 2:00 PM | Rm 208

32225 Life after AI deployment: A conversation on effective real-world performance monitoring

Mon., July 27 | 2:30 PM – 4:00 PM | Rm 207CD

32226 First, do no harm: Ethics at the crossroads of scientific integrity, AI, and DTC testing

Mon., July 27 | 2:30 PM – 4:00 PM | Rm 208

33102 Academy distinguished abstracts: Precision oncology diagnostics: AI, blood-based biomarkers, and longitudinal monitoring

Tue., July 28 | 10:30 AM – 12:00 PM | Rm 205

33108 ADLM Healthcare Forum: Future regulation and reimbursement for software and AI in the clinical laboratory

Tue., July 28 | 10:30 AM – 12:00 PM | Rm 210AB

33228 Academy guidance document on data analytics: Advancing data analytics maturity in the clinical laboratory for a data-driven future

Tue., July 28 | 2:30 PM – 4:00 PM | Rm 210AB

34106 The integration journey: Preparing clinical laboratorians for EHR/LIS implementation

Wed., July 29 | 10:30 AM – 12:00 PM | Rm 209

35102 Advancing equity in maternal drug testing: From ethical challenges to informatics solutions

Thu., July 30 | 10:30 AM – 12:00 PM | Rm 205

42105/52205 Reimagining the clinical laboratory: AI applications for today and the future

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

42106/52206 AI-driven precision medicine: Integrating wearable data streams to stratify cardio-metabolic risk and management

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43104/53204 Data literacy in the clinical lab: What do I need to know?

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43106/53206 The future of middleware solutions: Benefits, considerations, and the emergence of AI

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43107/53207 Complex data analysis for dummies: Using ChatGPT prompts to enhance data analysis through coding

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43125/53225 Understanding machine learning algorithms: Key considerations, it’s not magic, it’s math

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43131/53231 Automate, analyze, act: Leveraging Excel for lab data efficiency

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

44114/54214 Artificial intelligence driven supply chain management in clinical laboratories

Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

13001 Alzheimer disease biomarkers in Down syndrome

Tue., July 28 | 8:45 AM – 10:00 AM | RM Ballroom ABC

15001 Mass spectrometry-based discovery and translation of novel biomarkers into immune-based therapies for cancer

Thu., July 30 | 8:45 AM – 10:00 AM | Rm Ballroom ABC

32101 Biomarkers of traumatic brain injury: New guidance from the National Institute of Neurological Disorders and Stroke

Mon., July 27 | 10:30 AM – 12:00 PM | Rm 203

32103 Moving beyond creatinine to evaluate kidney function through novel biomarker panels

Mon., July 27 | 10:30 AM – 12:00 PM | Rm 206

32447 Clocking biological time: Measuring, standardizing, and influencing biological age

Mon., July 27 | 12:30 PM – 2:00 PM | Rm 209

32221 Enhancing CVD care: Leveraging new AHA/ACC guidelines, treatments, risk assessments, and innovative functional assays

Mon., July 27 | 2:30 PM – 4:00 PM | Rm 203

32223 Biomarkers for acute kidney injury: From physiology to practice with new clinical guidance

Mon., July 27 | 2:30 PM – 4:00 PM | Rm 206

33102 Academy distinguished abstracts: Precision oncology diagnostics: AI, blood-based biomarkers, and longitudinal monitoring

Tue., July 28 | 10:30 AM – 12:00 PM | Rm 205

33105 Transforming Alzheimer’s care: Implications of new clinical guidance

Tue., July 28 | 10:30 AM – 12:00 PM | Rm 207CD

33222 The sFlt-1:PlGF ratio in the evaluation of preeclampsia

Tue., July 28 | 2:30 PM – 4:00 PM | Rm 205

34222 Lipoprotein(a) could be the next public health revolution: Are clinical laboratories ready for the challenge?

Wed., July 29 | 2:30 PM – 4:00 PM | Rm 205

34227 Current and future landscape of tumor markers in clinical use: Applications, challenges, and perspectives

Wed., July 29 | 2:30 PM – 4:00 PM | Rm 210AB

35101 Beyond blood: The frontier of noninvasive fluid diagnostics

Thu., July 30 | 10:30 AM – 12:00 PM | Rm 203

35103 Update on thyroid function tests and efforts to improve their reliability

Thu., July 30 | 10:30 AM – 12:00 PM | Rm 206

42109/52209 Navigating clinical implementation challenges for traumatic brain injury (TBI) biomarker assays

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

42113/52213 Neurofilament light chain testing from start to finish: Challenges and implementation strategies for multiple sclerosis management

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

42125/52225 Exerkines: From molecular messengers of exercise to clinical biomarkers of health and resilience

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

42127/52227 Are we there yet? Clinical implementation of multi-cancer early detection (MCED) tests for preventive oncology

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43108/53208 Alzheimer’s disease biomarkers: Assay selection, performance considerations, and result interpretation

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43111/53211 Status of testosterone and estradiol testing in light of new guidelines and recommendations

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43128/53228 Impact of sFlt-1 and PlGF testing on the management of women with suspected preeclampsia in a high-risk obstetrics unit

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

44111/54211 Emerging blood-based biomarkers in neurodegenerative disease diagnosis and management

Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

191308 Regulatory round-up: Hands-on workshop for navigating common laboratory deficiencies in point-of-care testing (POCT)

Sun., July 26 | 9:00 AM – 4:00 PM | Room 

12001 Laboratory diagnostics for space medicine

Mon., July 27 | 8:45 AM – 10:00 AM | Rm Ballroom ABC

42110/52210 Alternative matrix samples: Challenges in body fluid testing and assay validation

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

42131/52231 Advanced care at home experience at Mayo Clinic and role of lab medicine

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43101/53201 Point of care on the fast track: Managing growth, complexity, and compliance for large POCT programs

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43103/53203 Raising the bar in point-of-care waived testing beyond regulatory minimums

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43114/53214 Unifying POCT lab critical result notification documentation with analytics insight

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

44101/54201 Empowering point-of-care excellence: Optimizing provider-performed microscopy (PPM) testing

Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

44102/54202 POCT in the autopsy suite: Screening for ketoacidosis as a cause of death

Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

44106/54206 ADLM remote sampling task force: Review and management topics

Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

44128/54228 What a pair: Implementing point of care viscoelastic testing in pediatric care

Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

32104 Wearable devices for diagnostics, is this point-of-care testing?

Mon., July 27 | 10:30 AM – 12:00 PM | Rm 207AB

32222 Newborn screening across Europe and the USA, what can we learn from each other?

Mon., July 27 | 2:30 PM – 4:00 PM | Rm 205

32224 POCT across the continuum: From real-time results to measurable impact

Mon., July 27 | 2:30 PM – 4:00 PM | Rm 207AB

33226 Addressing scientific gaps in POCT

Tue., July 28 | 2:30 PM – 4:00 PM | Rm 208

34221 Patient centric sampling for clinical diagnostics: Overcoming barriers to routine adoption

Wed., July 29 | 2:30 PM – 4:00 PM | Rm 203

34228 Alternative sampling for rapid toxicology screening by mass spectrometry

Wed., July 29 | 2:30 PM – 4:00 PM | Rm 210CD

35101 Beyond blood: The frontier of noninvasive fluid diagnostics

Thu., July 30 | 10:30 AM – 12:00 PM | Rm 203

11001 Diabetes prevention and treatment: A personal odyssey from bench to bedside

Sun., July 26 | 5:00 PM – 6:30 PM | Rm Ballroom ABC

13001 Alzheimer disease biomarkers in Down syndrome

Tue., July 28 | 8:45 AM – 10:00 AM | Rm Ballroom ABC

32103 Moving beyond creatinine to evaluate kidney function through novel biomarker panels

Mon., July 27 | 10:30 AM – 12:00 PM | Rm 206

32108 Beyond clinical care: Ethical, legal, and social implications of third-party uses of DNA

Mon., July 27 | 10:30 AM – 12:00 PM | Rm 210AB

32447 Clocking biological time: Measuring, standardizing, and influencing biological age

Mon., July 27 | 2:30 PM – 4:00 PM | Rm 203

32221 Enhancing CVD care: Leveraging new AHA/ACC guidelines, treatments, risk assessments, and innovative functional assays

Mon., July 27 | 12:30 PM – 2:00 PM | Rm 209

33101 Clinical Chemistry Journal hot topics: New approaches to personalized reference ranges

Tue., July 28 | 10:30 AM – 12:00 PM | Rm 203

33105 Transforming Alzheimer’s care: Implications of new clinical guidance

Tue., July 28 | 10:30 AM – 12:00 PM | Rm 207CD

33222 The sFlt-1:PlGF ratio in the evaluation of preeclampsia

Tue., July 28 | 2:30 PM – 4:00 PM | Rm 205

34102 Hypertensive disorders of pregnancy: Cardiovascular implications

Wed., July 29 | 10:30 AM – 12:00 PM | Rm 205

34107 Critical review and update of clinical guidelines for immune-mediated conditions: ANA reporting, antiphospholipid syndrome and multiple sclerosis

Wed., July 29 | 10:30 AM – 12:00 PM | Rm 210AB

34222 Lipoprotein(a) could be the next public health revolution: Are clinical laboratories ready for the challenge?

Wed., July 29 | 2:30 PM – 4:00 PM | Rm 205

34227 Current and future landscape of tumor markers in clinical use: Applications, challenges, and perspectives

Wed., July 29 | 2:30 PM – 4:00 PM | Rm 210AB

35102 Advancing equity in maternal drug testing: From ethical challenges to informatics solutions

Thu., July 30 | 10:30 AM – 12:00 PM | Rm 205

42106/52206 AI-driven precision medicine: Integrating wearable data streams to stratify cardio-metabolic risk and management

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

42113/52213 Neurofilament light chain testing from start to finish: Challenges and implementation strategies for multiple sclerosis management

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

42124/52224 Serology tests for celiac disease diagnosis and follow up in children

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

42127/52227 Are we there yet? Clinical implementation of multi-cancer early detection (MCED) tests for preventive oncology

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43108/53208 Alzheimer’s disease biomarkers: Assay selection, performance considerations, and result interpretation

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43122/53222 Beyond LDL-C: Case-based algorithms for complex lipid and lipoprotein profiles

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43128/53228 Impact of sFlt-1 and PlGF testing on the management of women with suspected preeclampsia in a high-risk obstetrics unit

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43130/53230 Therapeutic drug monitoring for hydroxychloroquine; teaching an old drug new tricks?

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

44111/54211 Emerging blood-based biomarkers in neurodegenerative disease diagnosis and management

Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

44124/54224 Interpreting high-sensitive cardiac troponin results: Sex-specific or uniform upper reference limits?

Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

44130/54230 Phosphatidylethanol (Peth) and post-liver transplant complications

Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

14001 Advances in screening for cervical cancer both in the United States and globally

Wed., July 29 | 8:45 AM – 10:00 AM | Rm Ballroom ABC

32106 Tick-borne diseases: Beyond Lyme disease

Mon., July 27 | 10:30 AM – 12:00 PM | Rm 208

32108 Beyond clinical care: Ethical, legal, and social implications of third-party uses of DNA

Mon., July 27 | 10:30 AM – 12:00 PM | Rm 210AB

32222 Newborn screening across Europe and the USA, what can we learn from each other?

Mon., July 27 | 2:30 PM – 4:00 PM | Rm 205

32226 First, do no harm: Ethics at the crossroads of scientific integrity, AI, and DTC testing

Mon., July 27 | 2:30 PM – 4:00 PM | Rm 208

32227 Measuring what matters: A practical framework for advancing equitable healthcare, diversity, equity, and inclusion in laboratory medicine

Mon., July 27 | 2:30 PM – 4:00 PM | Rm 209

33109 Recreational use of nitrous oxide: Clinical cases and laboratory detection

Tue., July 28 | 10:30 AM – 12:00 PM | Rm 210CD

33229 Clinical laboratory realities for effective overdose biosurveillance

Tue., July 28 | 2:30 PM – 4:00 PM | Rm 210CD

34102 Hypertensive disorders of pregnancy: Cardiovascular implications

Wed., July 29 | 10:30 AM – 12:00 PM | Rm 205

34105 The shot not taken: Dangers of declining vaccination rates and impacts to the lab

Wed., July 29 | 10:30 AM – 12:00 PM | Rm 208

34222 Lipoprotein(a) could be the next public health revolution: Are clinical laboratories ready for the challenge?

Wed., July 29 | 2:30 PM – 4:00 PM | Rm 205

42111/52211 Emerging environmental toxins: PFAS forever chemicals and beyond

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

42122/52222 Blood culture contamination rates: Collaboration for sustainable improvements

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

42127/52227 Are we there yet? Clinical implementation of multi-cancer early detection (MCED) tests for preventive oncology

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43112/53212 Ferritin cutoffs and iron deficiency: Harmonizing manufacturer reference intervals with recent guidelines to prevent missed diagnosis

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43123/53223 HIV diagnostics: 40 years later!

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

44115/54215 Exploring the solutions to hospitalization-associated iatrogenic anemia

Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

44118/54218From volume to value: Improving the outpatient lab requisition through evidence-based test selection

Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

44129/54229 Which specimen is best? Optimizing clinical toxicology workflows for the detection of in utero drug exposure

Wed, July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

14001 Advances in screening for cervical cancer both in the United States and globally

Wed., July 29 | 8:45 AM – 10:00 AM | Rm Ballroom ABC

32106 Tick-borne diseases: Beyond Lyme disease

Mon., July 27 | 10:30 AM – 12:00 PM | Rm 208

32446 Petri dishes and pixels: Applying digital imaging solutions to contemporary clinical microbiology practice

Mon., July 27 | 12:30 PM – 2:00 PM | Rm 208

33106 Behind the bench: Navigating safety and science in prion disease testing

Tue., July 28 | 10:30 AM – 12:00 PM | Rm 208

33225 Parasitology in the clinical lab, it’s not just for micro anymore

Tue., July 28 | 2:30 PM – 4:00 PM | Rm 207CD

34105 The shot not taken: Dangers of declining vaccination rates and impacts to the lab

Wed., July 29 | 10:30 AM – 12:00 PM | Rm 208

34225 Confronting antimicrobial susceptibility testing challenges: Tools from CLSI

Wed., July 29 | 2:30 PM – 4:00 PM | Rm 208

42102 Sepsis diagnostics today and tomorrow: From procalcitonin and lactate to new FDA-cleared assays and AI-driven portable MS

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

42122 Blood culture contamination rates: Collaboration for sustainable improvements

Mon., July 27 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

43123 HIV diagnostics: 40 years later!

Tue., July 28 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM

44122 Fungal taxonomy updates, Candida auris, and antifungal resistance testing in clinical laboratories

Wed., July 29 | 7:30 AM – 8:30 AM and 12:30 PM – 1:30 PM